ITERUM THERAPEUTICS PLC
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

1.770

+0.140 (+8.59%)
Range 1.560 - 1.830   (17.31%)
Open 1.710
Previous Close 1.630
Bid Price 1.150
Bid Volume 8
Ask Price 1.180
Ask Volume 12
Volume 1,868,761
Value -
Remark
Delayed prices. Updated at 22 Nov 2024 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis